Sphingolipids as targets for inhalation treatment of cystic fibrosis.
Becker KA, Riethmüller J, Seitz AP, Gardner A, Boudreau R, Kamler M, Kleuser B, Schuchman E, Caldwell CC, Edwards MJ, Grassmé H, Brodlie M, Gulbins E.
Becker KA, et al. Among authors: edwards mj.
Adv Drug Deliv Rev. 2018 Aug;133:66-75. doi: 10.1016/j.addr.2018.04.015. Epub 2018 Apr 24.
Adv Drug Deliv Rev. 2018.
PMID: 29698625
Review.